Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,699 | 38,907 | 49,983 | 64,532 | -107,458 |
| Depreciation Amortization | 15,362 | 11,446 | 7,570 | 3,773 | 12,937 |
| Accounts receivable | -27,573 | -9,337 | -9,868 | -44,353 | -11,512 |
| Other Working Capital | -58,743 | -39,210 | -42,553 | -69,801 | 84,326 |
| Other Operating Activity | 12,346 | -6,516 | -6,256 | 27,267 | 15,574 |
| Operating Cash Flow | $-16,909 | $-4,710 | $-1,124 | $-18,582 | $-6,133 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,394 | 101 | 6,771 | 74,216 | -19,957 |
| PPE Investments | -6,174 | -4,847 | -2,533 | -985 | -29,656 |
| Investing Cash Flow | $10,220 | $-4,746 | $4,238 | $73,231 | $-49,613 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,827 | 3,827 | 3,827 | 3,827 | 13,656 |
| Debt Repayment | N/A | N/A | N/A | N/A | -150 |
| Common Stock Issued | 1,502 | 683 | 603 | 274 | 94,678 |
| Common Stock Repurchased | -888 | -888 | N/A | N/A | N/A |
| Financing Cash Flow | $4,441 | $3,622 | $4,430 | $4,101 | $108,184 |
| Beginning Cash Position | 97,477 | 97,477 | 97,477 | 97,477 | 45,039 |
| End Cash Position | 95,229 | 91,643 | 105,021 | 156,227 | 97,477 |
| Net Cash Flow | $-2,248 | $-5,834 | $7,544 | $58,750 | $52,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,909 | -4,710 | -1,124 | -18,582 | -6,133 |
| Capital Expenditure | -6,174 | -4,847 | -2,533 | -985 | -29,656 |
| Free Cash Flow | -23,083 | -9,557 | -3,657 | -19,567 | -35,789 |